SE356979B - - Google Patents

Info

Publication number
SE356979B
SE356979B SE15032/68A SE1503268A SE356979B SE 356979 B SE356979 B SE 356979B SE 15032/68 A SE15032/68 A SE 15032/68A SE 1503268 A SE1503268 A SE 1503268A SE 356979 B SE356979 B SE 356979B
Authority
SE
Sweden
Application number
SE15032/68A
Inventor
K Weber
K Zeile
P Danneberg
R Giesemann
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of SE356979B publication Critical patent/SE356979B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE15032/68A 1967-11-24 1968-11-06 SE356979B (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT1064767A AT280290B (de) 1967-11-24 1967-11-24 Verfahren zur Herstellung von neuen 1-Phenyl-4-alkyl-3H-1,4-benzodiazepin-2,5-[1H,4H]-dionen

Publications (1)

Publication Number Publication Date
SE356979B true SE356979B (xx) 1973-06-12

Family

ID=3623762

Family Applications (1)

Application Number Title Priority Date Filing Date
SE15032/68A SE356979B (xx) 1967-11-24 1968-11-06

Country Status (13)

Country Link
AT (1) AT280290B (xx)
BE (1) BE724364A (xx)
BR (1) BR6804236D0 (xx)
CH (1) CH523265A (xx)
DE (1) DE1810423B2 (xx)
DK (1) DK124950B (xx)
ES (2) ES360410A1 (xx)
FR (2) FR1593335A (xx)
GB (1) GB1173540A (xx)
IE (1) IE32504B1 (xx)
IL (1) IL31146A (xx)
NL (1) NL6815755A (xx)
SE (1) SE356979B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3914216A (en) * 1962-12-18 1975-10-21 Boehringer Sohn Ingelheim 1-Phenyl-3H-1,4-benzodiazepine-2,5-(1H,4H)-diones
DE2117438A1 (de) * 1971-04-08 1972-10-19 CH. Boehringer Sohn, 6507 Ingelheim Neue substituiert 1,3-Dihydro-2H-1 ^-benzodiazepine^-one
BE793460A (fr) * 1971-12-29 1973-06-28 Boehringer Sohn Ingelheim Nouvelles 1-aryl-3h,1,4-benzodiazepine-2,5-(1h
US7572788B2 (en) 1999-04-30 2009-08-11 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
US7276348B2 (en) 1999-04-30 2007-10-02 Regents Of The University Of Michigan Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof
EP1398033B1 (en) * 1999-04-30 2009-06-17 The Regents Of The University Of Michigan Use of benzodiazepines for treating autoimmune diseases, inflammations, neoplasies, viral infections and atherosclerosis
US20060025388A1 (en) 1999-04-30 2006-02-02 Glick Gary D Compositions and methods relating to novel compounds and targets thereof
US7691582B2 (en) 2002-09-27 2010-04-06 The Regents Of The University Of Michigan Methods of secretory vimentin detection and modulation
EP1845996A4 (en) 2005-01-03 2009-04-29 Univ Michigan COMPOSITIONS AND METHODS RELATING TO NEW COMPOUNDS AND TARGETS
JP2008545757A (ja) 2005-06-01 2008-12-18 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 溶媒和されていないベンゾジアゼピン組成物および方法
NZ568254A (en) 2005-11-01 2011-06-30 Univ Michigan 1,4-Benzodiazepine-2,5-diones for regulating cell death and treating autoimmune diseases
US7759338B2 (en) 2006-04-27 2010-07-20 The Regents Of The University Of Michigan Soluble 1,4 benzodiazepine compounds and stable salts thereof
AU2007258468B2 (en) 2006-06-09 2011-09-22 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
NZ579507A (en) 2007-03-09 2011-11-25 Univ Michigan Compositions and methods relating to novel compounds and targets thereof
US9096546B2 (en) 2007-05-10 2015-08-04 Albany Molecular Research, Inc. Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
WO2009036175A2 (en) 2007-09-14 2009-03-19 The Regents Of The University Of Michigan F1f0-atpase inhibitors and related methods
WO2009061916A2 (en) 2007-11-06 2009-05-14 The Regents Of The University Of Michigan Benzodiazepinone compounds useful in the treatment of skin conditions
EP2352724B1 (en) 2008-09-11 2015-04-22 The Regents of the University of Michigan Aryl guanidine f1f0-atpase inhibitors and their medical use
WO2010121164A2 (en) 2009-04-17 2010-10-21 The Regents Of The University Of Michigan 1,4-benzodiazepinone compounds and their use in treating cancer
WO2011035124A1 (en) 2009-09-18 2011-03-24 The Regents Of The University Of Michigan Benzodiazepinone compounds and methods of treatment using same
AU2010322286B2 (en) 2009-11-17 2014-06-05 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
CA2780287C (en) 2009-11-17 2015-03-17 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
JP6863742B2 (ja) * 2013-09-11 2021-04-21 ジ・アドミニストレーターズ・オブ・ザ・チューレーン・エデュケーショナル・ファンド 新規アントラニルアミドとその使用

Also Published As

Publication number Publication date
DE1810423C3 (xx) 1973-10-11
FR1593335A (xx) 1970-05-25
CH523265A (de) 1972-05-31
IL31146A0 (en) 1969-01-29
NL6815755A (xx) 1969-05-28
AT280290B (de) 1970-04-10
FR8310M (xx) 1970-11-23
DK124950B (da) 1972-12-11
BE724364A (xx) 1969-05-22
IL31146A (en) 1972-04-27
BR6804236D0 (pt) 1973-02-08
ES360410A1 (es) 1970-11-01
IE32504B1 (en) 1973-08-22
GB1173540A (en) 1969-12-10
DE1810423A1 (de) 1969-10-09
IE32504L (en) 1969-05-24
DE1810423B2 (de) 1973-03-22
ES378977A1 (es) 1973-01-16

Similar Documents

Publication Publication Date Title
DE1810423C3 (xx)
AU2277767A (xx)
AU342066A (xx)
AU3151267A (xx)
AU2977667A (xx)
AU3189468A (xx)
AU2454867A (xx)
AU2116667A (xx)
AU2256867A (xx)
BE710310A (xx)
BE703561A (xx)
AU2406369A (xx)
AU1868267A (xx)
AU1763766A (xx)
AU1677166A (xx)
BE711675A (xx)
BE711542A (xx)
BE710951A (xx)
BE710614A (xx)
BE709526A (xx)
BE710224A (xx)
BE710000A (xx)
BE709730A (xx)
BE709564A (xx)
BE692553A (xx)